Insider Transactions in Q2 2021 at Processa Pharmaceuticals, Inc. (PCSA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2021
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
10,000
+2.82%
|
$70,000
$7.67 P/Share
|
|
Jun 22
2021
|
Robert Michael Floyd Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+6.67%
|
$14,000
$7.03 P/Share
|
|
Jun 21
2021
|
James H Stanker Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+2.67%
|
$6,000
$6.81 P/Share
|
|
Jun 21
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
2,000
+0.5%
|
$12,000
$6.65 P/Share
|
|
Apr 14
2021
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
9,700
-3.76%
|
$87,300
$9.42 P/Share
|
|
Apr 13
2021
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
6,500
-2.46%
|
$58,500
$9.86 P/Share
|
|
Apr 08
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
400,000
-38.16%
|
$4,000,000
$10.76 P/Share
|
|
Apr 07
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
16,000
-1.5%
|
$160,000
$10.67 P/Share
|
|
Apr 06
2021
|
James E Besser |
SELL
Open market or private sale
|
Direct |
31,771
-2.9%
|
$317,710
$10.91 P/Share
|